Noxopharm is an innovative biotechnology company with a science driven strategy to advance the most promising life-saving therapies for patients with cancer or inflammatory diseases, through the discovery, preclinical and clinical phases.
The company's focus is on adding value to its assets at each step of the development process.
A targeted product pipeline is core to Noxopharm’s success. We achieve this by leveraging the expertise of our scientific team and developing new technologies in house, as well as by working with leading scientific and medical researchers globally.